// App-Quantinova.ai

P50.03 : A Real-World Cohort Study of EGFR TKIs in Patients with NSCLC with Uncommon EGFR mutations (UpSwinG)

Researchers

Presenter

  • S. Miura

Principal Investigators

  • J. Hung

  • H.A. Jung

  • J. Shih

  • C. Park

  • S.H. Lee

  • T. Okamoto

  • H.K. Ahn

  • Y.C. Lee

  • Y. Sato

  • S.S. Lee

  • H. Daoud

  • S. Popat

Medical Centers

  • INJE University Haeundae Paik Hospital, INJE University College of Medicine, Busan/KR

  • Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun/KR

  • Department of Internal Medicine, Research Institute of Clinical Medicine of Chonbuk National University, Biomedical Research Institute of Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju/KR

  • Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata City, Japan

  • Division of Medical Oncology, Gachon University Gil Medical Center, Incheon/KR

  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan, Kaohsiung, Taiwan

  • Lung Unit, Royal Marsden National Health Service Foundation Trust, London/united Kingdom; the Institute of Cancer Research, London/GB

  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea

  • Department of Respiratory Medicine, Kobe City Medical Center, General Hospital, Kobe, Japan

  • Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan

  • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

  • Pulmonary Department, Strasbourg University, Strasbourg University Hospital, Strasbourg/FR

  • Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

  • Department of Internal Medicine, China Medical University Hospital, Department of Respiratory Therapy, China Medical University, Taichung/TW

  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany,

Locations

  • United States

  • United Kingdom

  • Taiwan

  • France

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Epidermal growth factor receptor

  • Threonine at amino acid position 790

Drug/Treatment

  • Tagrisso

  • Erlotinib hydrochloride

  • gefitinib

  • Afatinib

Outcome

  • N/A

Study Design

  • Non Interventional

  • Multicenteric

  • Cohort

Phase

  • N/A

Study Id's

  • NCT04179890

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved